Modern diabetes management is no longer just about lowering blood sugar levels. This program examines oral semaglutide through a broader lens, focusing on the clinical benefits that extend well beyond glucose control. We analyze the latest data regarding weight management and cardiovascular risk reduction, providing a holistic view of the patient’s metabolic health. It is an essential update for clinicians who want to move past traditional metrics and provide comprehensive protection for their patients.